Arcellx Inc’s Anito-cel: Promising Efficacy and Best-in-Class Safety Profile Justify Buy Rating
Analyst John Newman from Canaccord Genuity maintained a Buy rating on Arcellx Inc (ACLX – Research Report) and keeping the price target ...
Exxon Mobil’s Strategic Growth and Emission-Reduction Initiatives Justify Buy Rating
Analyst Suvro Sarkar of DBS maintained a Buy rating on Exxon Mobil (XOM – Research Report), retaining the price target of $133.00. Suvro ...